Ml. Dickens et al., IN-VIVO AND IN-VITRO BIOCONVERSION OF EPSILON-RHODOMYCINONE GLYCOSIDETO DOXORUBICIN - FUNCTIONS OF DAUP, DAUK, AND DOXA, Journal of bacteriology, 179(8), 1997, pp. 2641-2650
We recently determined the function of the gene product of Steptomyces
sp. strain C5 doxA, a cytochrome P-450-like protein, to be daunorubic
in C-14 hydroxylase (M. L. Dickens and W. R. Strohl, J. Bacteriol, 178
: 3389-3395, 1996), In the present study, we show that DoxA also catal
yzes the hydroxylation of 13-deoxycarminomycin and 13-deoxydaunorubici
n to 13-dihydrocarminomycin and 13-dihydrodaunorubicin, respectively,
as well as oxidizing the 13-dihydro-anthracyclines to their respective
13-keto forms, The Streptomyces sp, strain C5 dauP gene product also
was shown unequivocally to remove the carbomethoxy group of the epsilo
n-rhodomycinone-glycoside (rhodomycin D) to form 10-carboxy-13-deoxyca
rminomycin. Additionally, Streptomyces sp, strain C5 DauK was found to
methylate the anthracyclines rhodomycin D, 10-carboxy-13-deoxycarmino
mycin, and 13-deoxy-carminomycin, at the 4-hydroxyl position, indicati
ng a broader substrate specificity than was previously known, The prod
ucts of Streptomyces sp. strain C5 doxA, dauK, and dauP were sufficien
t and necessary to confer on Streptomyces lividans TK24 the ability to
convert rhodomycin D, the first glycoside in daunorubicin and doxorub
icin biosynthesis, to doxorubicin.